This compound is an oxalate salt form of a substituted benzonitrile derivative. It is primarily used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 717133-32-9
Citadiol
pharmaceutical intermediate
Citadiol hydrobromide
pharmaceutical intermediate
Citadiol hydrochloride
pharmaceutical intermediate
Methyl 4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
pharmaceutical intermediate
3-Bromo-2-methoxy-6-methylpyridine
pharmaceutical intermediate
3-Bromo-2-[(propan-2-yl)oxy]pyridine
pharmaceutical intermediate
Ethylphenylcyano-acetic acid ethyl ester
pharmaceutical intermediate
(S)-citadiol hemi-bis-4-toluoyl-D-tartrate
pharmaceutical intermediate
4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile;oxalic acid
FVHFLMVLFQFEHN-UHFFFAOYSA-N
CN(C)CCCC(C1=CC=C(C=C1)F)(C2=C(C=C(C=C2)C#N)CO)O.C(=O)(C(=O)O)O
—